Form 10-Q CATABASIS PHARMACEUTICAL For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Catabasis Pharma (CATB) Tops Q3 EPS by 11c
November 10, 2016 4:13 PM ESTCatabasis Pharma (NASDAQ: CATB) reported Q3 EPS of ($0.54), $0.11 better than the analyst estimate of ($0.65).
For earnings history and earnings-related data on Catabasis Pharma (CATB) click here.
... More